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Abstract  
Chronic itch is a debilitating condition characterised by excessive scratching and is a symptom 
frequently reported in skin diseases such as atopic dermatitis. It has been proposed that 
release of the cysteine protease Cathepsin S (CatS) from skin keratinocytes or immune cells 
resident in or infiltrating the skin could act as a pruritogen in chronic itch conditions. CatS is 
known to activate protease-activated receptor 2 (PAR2). We therefore hypothesised that 
enzymatic activation of neuronally expressed PAR2 by CatS was responsible for activation of 
sensory neurons and transmission of itch signals. Intradermally-injected human recombinant 
(hr)-CatS or the PAR2 agonist, SLIGRL-NH2 behaved as pruritogens by causing scratching 
behaviour in mice. Hr-CatS-induced scratching behaviour was prevented by CatS inhibitors 
and PAR2 antagonists and reduced by 50% in TRPV1-/- mice compared with wild-type mice, 
whilst no significant reduction in scratching behaviour was observed in TRPA1-/- mice. Cultured 
dorsal root ganglion (DRG) cells showed an increase in [Ca2+]i following  incubation with hr-
CatS, and the percentage of neurons that responded to hr-CatS decreased in the presence of 
a PAR2 antagonist or in cultures of neurons from TRPV1-/- mice. Taken together, our results 
indicate CatS acts as a pruritogen via PAR2 activation in TRPV1-expressing sensory neurons. 
 
 
Key words: itch, proteases, sensory neurons 
 
 
 
 
 
 
 
 
3 
 
Introduction  
Itch is defined as an unpleasant sensation in the skin associated with the urge to scratch 
(Steinhoff et al., 2006). Acute itch is a beneficial sensation that encourages scratching to 
remove irritants and potentially harmful agents from the skin (Green and Dong, 2016; Hoon, 
2015; Ross, 2011). However, in chronic itch conditions such as atopic dermatitis (AD), 
excessive scratching of the skin results in inflammation and exacerbates the itch, culminating 
in an “itch-scratch cycle” (Steinhoff et al., 2006). Anti-histamines have been used to treat itch, 
although they are reported to have limited efficacy in AD (Andersen et al., 2017; Klein and 
Clark, 1999; Rukwied et al., 2000; Wahlgren et al., 1990; Yarbrough et al., 2013). It has thus 
been suggested that itch in AD is due to pruritogens other than histamine acting on sensory 
neurons. The sensory neurons that convey itch signals, or pruriceptors, mostly belong to a 
subset of nociceptors expressing the TRPV1 receptor (Liu and Ji, 2013). Neurons that respond 
to pruritogens other than histamine are proposed to additionally express the TRPA1 receptor, 
and it is likely that the neurons involved in AD and other chronic itch conditions belong to this 
population of pruriceptors (Bautista et al., 2013; Wilson et al., 2011) .  
Following activation by pruritogens, neurotransmitters such as glutamate and neuropeptides  
such as natriuretic polypeptide B are released from the central terminals of pruriceptors in the 
outer laminae of the spinal cord dorsal horn (Green and Dong, 2016; Hoon, 2015). The signal 
is then transmitted through a series of interneurons where the signal may become modified, 
for instance by incoming signals from nociceptive neurons that can inhibit transmission of 
pruriceptive information by interacting with the itch circuitry. From the projection neurons in 
lamina I of the dorsal horn, the neurons conveying pruriceptive signals decussate and ascend 
along the spinothalamic tract to the thalamus and higher brains centres, where the itch 
sensation is perceived (Hoon, 2015). 
Besides histamine-sensitive fibres, itch is generated by recruitment of cutaneous nerve fibres 
that respond to mast cell derived-tryptase and activation of protease-activated receptor 2 
(PAR2).  Recent observations in healthy human subjects indicate that PAR2 receptor-
mediated itch can also be elicited by the cysteine protease cathepsin S (CatS): human 
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recombinant CatS (hr-CatS) applied to human skin can induce itch within minutes (Reddy et 
al., 2010).  In addition, hr-CatS activates PAR2 receptors heterologously expressed in HeLa 
cells (Elmariah et al., 2014)⁠. CatS is not normally expressed in keratinocytes, but it is up-
regulated in inflammatory conditions such as AD (Schonefuss et al., 2010). Consistently, 
CatS-overexpressing transgenic mice develop a skin disorder similar to chronic AD (Kim et 
al., 2012). Cleavage of PAR2 by proteases results in the sensitisation of TRP channels, 
including TRPV1 and TRPA1 (Amadesi, 2004; Amadesi et al., 2006; Chen et al., 2011; Dai, 
2004; Dai et al., 2007; Mrozkova et al., 2016), which may be responsible for the transmission 
of itch signals in pruriceptors. CatS causes visceral hypersensitivity through PAR2-mediated 
mechanisms (Cattaruzza et al., 2011). However, whether activation of neuronally-expressed 
PAR2 by CatS results in activation of neurons, sensitisation of TRP channels and transmission 
of itch signals has not been fully addressed. 
The aim of this study was to investigate whether CatS could act directly on neurons to activate 
them and result in transmission of itch signals. We first established a mouse model of CatS-
induced itch to investigate whether TRPV1 and TRPA1 were required for scratching  following 
intradermal injection of CatS. The responses of cultured dorsal root ganglion (DRG) cells to 
application of CatS were then investigated and the neurons that responded to CatS were 
characterised. 
 
Materials and Methods  
Animals  
Experiments were performed in accordance with the United Kingdom Home Office 
Regulations (Scientific Procedures Act, 1986) in adult male C57BL/6 mice, 12-17 weeks of 
age.  Mice were housed in the Biological Services Unit, King’s College London, and 
maintained in a 12 hour day/night cycle, with access to food and water ad libitum. Wild-type 
mice were obtained from Charles River while TRPV1-/-, TRPA1-/- and TRPV1-/-/TRPA1-/- mice 
were a gift from Professor Stuart Bevan, King’s College London. Animals were allowed 
acclimatisation for 7 days before experiments and habituated for 30 minutes a day at least 3 
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days prior to the experiment and on the day of the study.  
Behaviour 
At least 24 hr prior to experiments an area at either the nape of the neck (1.5 cm2) or the cheek 
was shaved in preparation to intra-dermal injection of pruritic agents (50 or 10 l total volume 
using a 0.3 ml Myjector 29G insulin syringe) and mice were habituated to the observation 
chamber for 30 min. Experimenters were blind to genotype and treatment. 
In the nape of the neck model, mice were monitored for scratching behaviour immediately post 
pruritic agent injection for 15 min.  A scratch was defined as a rapid back-and-forth lifting of 
the hind paw to the injected area. Both the time spent scratching (seconds) and number of 
paw lifts (itching bouts) were recorded and data expressed as time spent scratching and 
number of foot lifts. The composite score (the two readings added together) was quantified 
over the 15 min and at 5 min intervals. 
In the cheek injection model (Shimada and LaMotte, 2008)⁠, scratching was defined as a 
continuous movement of the hind paw at the site of injection, while wiping was defined as a 
stroking movement of the forepaw over the injected portion of the cheek. Total scratching and 
wiping behaviour and scratching over the 15 min observation period were quantified.  
Materials and Compounds 
Human recombinant CatS (hr-CatS), LHVS (morpholinurea-leucine-homophenylalanine-
vinylsulfone-phenyl (Barclay et al., 2007) and MDV-590 ((S)-N-(1-((1-(2-amino-2-
oxoacetyl)cyclobutyl)amino)-3-(1-fluorocyclopentyl)-1oxopropan-2-yl)3,3,3-trifluoro-2,2-
dimethylpropanamid) (Sohlenius-Sternbeck et al., 2017) and a close analogue  of the selective 
inhibitor MIV-247 (described in Hewitt et al., 2016) were supplied by Medivir, Huddinge, 
Sweden.  
Buffer exchanged, de-salted and heat inactivated CatS or activated hr-CatS (activity 46 µmol 
AMC (7-amino-4-methylcoumarin) produced/minute/mg; concentration of 0.38 mg/ml by active 
site titration) (Hewitt et al., 2016) was injected at doses of 1 – 20 µg/50 µl/mouse-which was 
the highest deliverable dose due to solubility in saline (vehicle). LHVS was dissolved in 20% 
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cremophore/saline and injected subcutaneously at a dose of 30 mg/kg, 1 hr before intradermal 
hr-CatS. MDV-590 was supplied pre-formulated in 20% HP-β-CD (2-hydroxypropyl)--
cyclodextrin), at 40 mM concentration and administered via oral gavage at a dose of 200 
µmol/kg, 1 hr before intradermal hr-CatS. The PAR2 agonist SLIGRL-NH2 (10, 50 and 
100 µg/50 µl/mouse, (Insight Biotechnology, Wembley, United Kingdom) and antagonist 
FSLLRY-NH2 (50 µg/50 µl/mouse) (Sigma) as well as chloroquine sulphate (200 
g/10l/mouse) and capsaicin (10 g/10l/mouse) (Sigma) were dissolved in saline and 
injected intradermally.  
Calcium imaging in cultured dorsal root ganglia 
Mice were killed by an overdose of sodium pentobarbital, and dissociated DRG were prepared 
as reported previously (Simeoli et al., 2017). DRGs from all spinal levels were collected and 
placed in a dish of Ham's DMEM F-12 and treated with type-4 collagenase (Worthington, Lorne 
Laboratories, Reading, United Kingdom; 0.125% w/v) for up to 120 mins at 37°C. Following 
trituration, cells were plated on glass coverslips pre-coated with poly-L-ornithine and collagen 
and incubated for 18-24 hrs at 37°C. 
Cultured DRG neurons were loaded with Fura-2-AM (2 μM; Teflabs, Cambridge Bioscience, 
Cambridge, UK) for 60 minutes at 37°C in Hank’s balanced salt solution (with calcium and 
magnesium and without phenol red, Thermo Fisher, Loughborough, UK) supplemented with 
10 mM HEPES (Sigma).  Coverslips were mounted in an open chamber and substances were 
applied by continuous perfusion and hr-CatS was incubated for up to 20 minutes. In some 
experiments, cells were pre-incubated in MDV-590 (0.5 μM) or FSLLRY-NH2 (5 μM) for 10 
minutes followed by application of hr-CatS in the presence of MDV-590 or FSLLRY-NH2. The 
fluorescence of individual cells was measured at 340 and 380 nm excitation and 510 nm 
emission with a Flexstation (Molecular Devices, Wokingham, UK) using PTI Easy Ratio Pro 
software (version 1.2.1.87) every 2 seconds. KCl (Sigma; 50 mM) was applied to all cells at 
the end of each experiment to provide a maximal Ca2+ signal against which to normalise 
responses to other substances and activate all viable cells to allow for comparisons of the 
7 
 
percentage of cells that responded to activation of each substance. A cell was considered to 
have responded to application of a substance if the response to that substance was at least 
20% of the size of the response of the same cell to application of KCl. 
Data and statistical analyses 
The time spent scratching (seconds) and the number of itching bouts were expressed 
separately, and also combined in order to provide a composite itch score during a 15 min 
observation period.   Data are expressed at mean + SEM. Time course data were analysed 
using Two-way ANOVA followed by Dunnett’s test. Combined data over the 15 min 
observation period were analysed using One-Way ANOVA followed by Dunnett’s test. Post-
treatment combined data were analysed with paired/unpaired Student’s t test and Mann-
Whitney U test. Calcium imaging data were analysed using GraphPad Prism 5 and are 
presented as the mean ± SEM. n represents the number of experiments analysed. Statistical 
analyses were conducted using one-way ANOVA followed by Dunnett's multiple comparison 
test versus 20 minutes buffer incubation to determine the percentage of cells that responded 
to application of substances.  
 
Results 
Acute injection of Cathepsin S induces scratching behaviour 
Intradermal injection of hr-CatS (1 – 20 μg/mouse) at the nape of the neck induced significant 
scratching behaviour compared to saline injection, as indicated by the time spent scratching 
the neck area during a 15 min observation period (Fig. 1A), number of paw lifts towards the 
neck (itching bouts, measured as scratching-which it is assumed are in response to an itch) 
(Fig. 1B), composite scores obtained by combining time and itching bouts (Fig. 1C) and total 
behaviour scores (Fig. 1D). All itching time and itching bouts behaviour parameters reached 
statistical significance at 10 min after injection of 20 μg of hr-CatS and ceased by 15 min after 
injection (Fig. 1A – D).  The injection of heat inactivated hr-CatS (20 μg/mouse) did not induce 
scratching behaviour (Fig.1 A-D). As expected, the PAR2 receptor agonist SLIGRL-NH2 (10 – 
100 μg/mouse) also induced scratching behaviour following intradermal injection at the neck 
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(Fig. 2A – D). At 5 min after 50 or 100 μg/mouse, SLIGRL-NH2 injection was associated with 
significant time spent scratching (Fig. 2A) and significant paw lifts towards the neck (itching 
bouts) (Fig. 2B), which resulted in significant composite scores (Fig. 2C) and total behaviour 
scores (Fig. 2D). Total SLIGRL-NH2 itch-like behaviour values were nearly double those 
associated with CatS (102.2±30.5 vs. 55.4±9.6 respectively), which nevertheless produced 
significant pruritic effect at the highest deliverable dose according to solubility in saline 
(vehicle).    
As local injection of hr-CatS in peripheral sites (intraplantar) is known to exert a pro-
nociceptive effect (Barclay et al., 2007; Zhao et al., 2014), we differentiated CatS-induced itch-
like behaviour from pain-like behaviour using the cheek injection model in which wiping (pain-
related) and scratching (itch-related) behaviour can be recorded. We observed that hr-CatS 
(20 μg/mouse) induced wiping behaviour, which lasted for less than 10 seconds, but also 
scratching behaviour, which lasted for an average of 25 seconds over the 15 min-observation 
period (Fig. 3A).  As expected, the injection of saline resulted in hardly any wiping or scratching 
behaviour (as shown in Fig. 1 and Fig. 2). The injection of SLIGRL-NH2 into the cheek also 
resulted in scratching, but no wiping behaviour (Fig. 3B) and this pattern was observed with 
the itch agent, chloroquine (Fig. 3C) whilst the injection of the pro-nociceptive agent capsaicin 
into the cheek was associated with wiping behaviour and no scratching (Fig. 3D).  These 
experiments in the cheek injection model confirm that intradermal CatS, which induces itch 
sensation in humans, is also a pruritic agent in the mouse. Thus, we examined whether CatS-
induced itch was blocked by CatS inhibitors and/or by a PAR2 receptor antagonist as there is 
evidence for a role of the PAR2 receptor in human studies.  
 
Cathepsin S-induced scratching behaviour is prevented by cathepsin S inhibitors and 
a PAR2 receptor antagonist. 
Systemic administration of the irreversible CatS inhibitor LHVS (30 mg/kg s.c.), 1 hr before 
intradermal hr-CatS, significantly reduced itch-like behaviour, which was recorded as time 
spent scratching, number of itching bouts and the composite score (Fig. 4A). Similarly, 
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administration of the reversible CatS inhibitor MDV-590 (200 μmol/kg p.o.) 1 hr before hr-CatS 
significantly reduced time spent scratching, number of itching bouts and the composite score 
(Fig. 4B). These data indicate that enzymatic activity is required for the behavioural effect 
associated with administration of CatS. Then, as we postulated that PAR2 receptors 
expressed by primary afferent fibres could be substrate for CatS, we tested the effect of 
systemic pre-treatment with a PAR2 receptor antagonist. We observed that FSLLRY (50 μg/kg 
i.d.) prevented CatS-induced scratching behaviour (Fig. 4C) and also SLIGRL-NH2 -induced 
itch-like behaviour (Fig. 4D), suggesting that PAR2 receptor activation mediates the effect of 
CatS.  
CatS-induced scratching behaviour requires TRPV1 receptor 
As cleavage of PAR2 by proteases results in the sensitisation of TRP channels in sensory 
neurons, we assessed CatS-induced itch-like behaviour in TRPV1-/-, TRPA1-/-, TRPV1-/-
/TRPA1-/- double transgenic mice. For comparison purposes we also evaluated SLIGR-NH2-
induced itch-like behaviour in the transgenic mice. We observed that in TRPV1-/-  mice, hr-
CatS-induced scratching behaviour was significantly reduced as time spent scratching, 
number of itching bouts and the composite score were lower than in WT mice (Fig. 5A). 
However, SLIGR-NH2-induced itch-like behaviour was unaltered in TRPV1-/- mice, which 
showed comparable time spent scratching, number of itching bouts and the composite score 
to WT controls (Fig. 5B).  In contrast, hr-CatS-induced scratching behaviour was unaltered in 
TRPA1-/- (Fig. 5C) whereas SLIGRL-NH2-induced scratching behaviour was reduced by 80% 
(Fig. 5D). Predictably, in TRPV1-/-/TRPA1-/- mice, both CatS- and SLIGR-NH2-induced itch-
like behaviour was significantly reduced compared to WT mice (Fig. 5 E, F). This set of data 
suggest that TRPV1 is required for CatS-induced itch and confirm the requirement of TRPA1 
receptor for SLIGRL-NH2-mediated itch.  
 
Sensory neurons respond to CatS 
To examine whether sensory neurons could respond directly to the application of CatS, 
cultured mouse DRG neurons were incubated with hr-CatS, which induced an increase in 
10 
 
intracellular calcium concentration following incubation at 400 nM for 20 minutes in cells that 
subsequently responded to KCl incubation (Fig. 6A).  Specifically, more than 15% of cells 
responded to hr-CatS, which was significantly greater than the percentage that responded to 
application of buffer for the same duration (Fig. 6B). Some cells also responded following 
exposure to hr-CatS for 2 or 10 minutes, although this was not significantly different compared 
with the percentage that responded to buffer (Fig 6B). 
When DRG neurons were incubated with the CatS inhibitor MDV-590 for 10 min prior to hr-
CatS, the percentage of cells that responded to hr-CatS was reduced by more than 50% 
compared to the percentage that responded to hr-CatS in the absence of the inhibitor, and 
was similar to the percentage that responded to buffer (Fig. 6C). Similarly, incubation of DRG 
neurons with the PAR2 antagonist FSLLRY-NH2 (10 min prior to hr-CatS) also resulted in a 
significant reduction of the percentage of cells that responded to hr-CatS (Fig. 6C). These data 
suggest that PAR2 receptors mediate CatS-induced calcium fluxes in DRG neurons. 
Finally, in order to test for the involvement of TRPV1 and TRPA1 channels on the effect of 
CatS we used DRG neurons from TRPV1-/- and TRPA1-/- mice and observed that the 
percentage of cells responding to hr-CatS was reduced in both conditions (Fig. 6D). 
Discussion  
In agreement with previous observations in humans (Reddy et al., 2010), we report that CatS 
is a pruritogen eliciting scratching behaviour when injected into mice. CatS-induced scratching 
was prevented by CatS inhibitors and PAR2 antagonist suggesting that PAR2 enzymatic 
activation mediates CatS-induced itch. In addition, CatS-induced scratching was reduced by 
50% in TRPV1-/- mice, supporting a role for TRPV1 in CatS-induced itch. In contrast, 
scratching behaviour was not significantly reduced in TRPA1-/- mice, suggesting this channel 
may not be required for CatS-induced scratching. The opposite was observed for SLIGRL-
induced scratching behaviour, with TRPV1 appearing to be dispensable for SLIGRL-induced 
behaviours while expression of functional TRPA1 was required.  
Application of CatS to DRG neurons in culture resulted in intracellular calcium increase, 
suggesting neurons can respond directly to CatS. The percentage of cells that responded to 
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CatS is similar to the ~7% of mouse DRG neurons that were reported to respond in a previous 
study (Reddy et al., 2015), with the majority of responding cells in our study showing an 
increase in intracellular calcium within 2 minutes of CatS application. 
Responses to CatS were prevented by the CatS inhibitor, MDV-590, confirming the calcium 
fluxes observed were due to the enzymatic activity of CatS. The effect of CatS was also 
prevented by the PAR2 antagonist FSLLRY-NH2, suggesting that PAR2 mediated the effects 
of CatS. Moreover, the percentage of cells that responded to CatS was comparable to the 
percentage of mouse DRG cells in culture reported to express PAR2 mRNA (Vellani et al., 
2010). However, the observation that CatS and SLIGRL-induced scratching behaviours had 
different time courses and were differentially affected in transgenic mice lacking functional 
TRPV1 or TRPA1 suggests CatS and SLIGRL may work via different mechanisms. For 
instance, SLIGRL can activate PAR2 immediately on contact, whereas the CatS would need 
time for the proteolytic cleavage.  It has recently been reported that CatS, SLIGRL-NH2 and 
mucunain can act via MrgprC11 in addition to PAR2 (Liu et al., 2011; Reddy et al., 2015, 2018). 
One possibility is that activation of sensory neurons in vivo by CatS or SLIGRL-NH2 results in 
differential activation of these receptors, which could explain our observations. In contrast, 
preventing activation of PAR2 in vitro appears to be sufficient to prevent CatS-induced calcium 
responses in DRG neurons. The finding that CatS -mediated calcium transients can be 
reduced in the presence of a PAR2 antagonist is not in agreement with previous reports that 
CatS -mediated calcium fluxes were not abolished in DRG cultures from PAR2-/- mice (Reddy 
et al., 2015)⁠. However, CatS at 2 – 5 μM concentration was used in these experiments, while 
we used CatS at a lower concentration (400 nM). It cannot be excluded that CatS when used 
at higher concentrations could activate additional receptors, such as Mrgprs, while PAR2 could 
be preferentially cleaved with lower concentrations of CatS. Several in vitro and in vivo 
observations indicate that human CatS can disarm mouse PAR2 receptor: i) human and 
mouse PAR2 receptors share more than 80% identity (Bohm et al., 1996); ii)  hr-CaS  cleaves 
mouse PAR2 receptors at two sites (Elmariah et al., 2014; Zhao et al., 2014) and ii) PAR2 
antagonists block intraplanar hr-CatS-induced pain in mice (Zhao et al., 2014).  
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CatS-induced calcium responses were also reduced in DRGs cultured from TRPV1-/- or 
TRPA1-/- mice, supporting a role for these channels in activation of sensory neurons by CatS 
and the subsequent transmission of itch signals. This is in agreement with the notion that 
pruriceptors belong to a subset of TRPV1 and TRPA1-expressing neurons (Liu and Ji, 2013). 
Activation of these receptors results in the opening of channels to form a pore allowing the 
passage of cations including calcium and sodium. The calcium fluxes observed following 
activation and opening of these channels can be prevented by the removal of extracellular 
calcium from the buffer, suggesting that most or all of the calcium is derived from the 
extracellular environment (Caterina et al., 1997; Jordt et al., 2004).  
The observation that calcium responses to CatS in vitro required expression of both TRPV1 
and TRPA1 channels is surprising given that TRPA1 was shown to be dispensable for CatS-
induced scratching behaviour. One explanation for this is the difference between in vivo 
behavioural studies and in vitro assays used to investigate the responses of cells, which may 
not necessarily be the same; in this instance we are assuming that calcium fluxes and 
activation of cells means transmission of itch signals and subsequent scratching behaviour. 
Compensatory mechanisms may exist in TRPA1-/- mice such that no obvious defects in CatS-
mediated scratching are observed. For instance, it has been reported that CFA-induced 
hyperalgesia is reduced in wild-type mice pre-treated with a TRPA1 inhibitor, while TRPA1-/- 
mice still displayed hyperalgesia (Petrus et al., 2007). Changes in the expression of other TRP 
channels in DRGs and other cell types are proposed to be responsible for this, and a similar 
compensatory mechanism may allow for CatS-induced scratching behaviour in TRPA1-/- mice, 
even in the absence of calcium responses in DRGs in vitro. Alternatively, because TRPV1 and 
TRPA1 are also reported to be expressed on skin keratinocytes and mast cells as well as 
sensory neurons (Atoyan et al., 2009; Bíró et al., 1998; Inoue et al., 2002), the presence or 
absence of these channels on non-neuronal cells could also be mediating an indirect effect on 
CatS-induced scratching in behavioural studies which would not be detected in neuronal 
calcium imaging experiments. Thus, although CatS did not cause calcium responses in 
neurons cultured from TRPA1-/- mice, itch sensations and scratching behaviour might still 
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occur, for instance, via release of histamine from mast cells and sensitisation or compensation 
of TRPV1 expressed on neurons or other cells. Since PAR2 sensitises TRPV1 and TRPA1, 
we hypothesise cleavage of neuronal PAR2 by CatS is responsible for this sensitisation. 
Cleavage of PAR2 by trypsin has previously been reported to sensitise TRPV1 via 
phosphorylation by protein kinases C and A, and PAR2-mediated sensitisation occurs by 
hydrolysis of PIP2 by PLC (Amadesi, 2004; Amadesi et al., 2006; Dai, 2004; Dai et al., 2007). 
However, whether CatS causes sensitisation of neuronally-expressed TRPV1 and TRPA1 by 
the same mechanisms is not yet known. It would therefore not be so surprising if the 
mechanisms by which TRPV1 and TRPA1 became sensitised by PAR2 were the same 
following cleavage of PAR2 by CatS compared with trypsin.   
In summary, CatS is a pruritogen that causes scratching behaviour when injected in mice and 
activates sensory neurons in culture. TRPV1 is required for both CatS-induced scratching 
behaviour and CatS-mediated calcium fluxes in vivo.  As CatS inhibitors are effective at 
preventing CatS-induced itch, this model can be used as a translational model as well as for 
testing new indications for CatS inhibitors. 
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Legends  
Figure 1. Activated recombinant hr-CatS induces itch-like behaviour. A) Itching time (time 
spent scratching) over the 15 min observation period after intradermal injection in the nape of 
the neck. B) Number of paw lifts (Itching bouts) over the 15 min observation period. C) 
Composite scores over the 15 min observation period. D) Total sum behaviour over the 15 
min observation period.  Data are mean + SEM of 10 mice per group. *P<0.05, **P<0.01, Two-
way ANOVA followed by Dunnett’s test versus 1 µg in panels A, B and C. One Way ANOVA 
followed by Dunnett’s test versus 1 µg dose in composite behaviour (panel D). 
 
Figure 2. SLIGRL-NH2 induces itch-like behaviour. A) Itching time (time spent scratching) 
over the 15 min observation period after intradermal injection in the nape of the neck. B) 
Number of paw lifts (Itching bouts) over the 15 min observation period. C) Composite scores 
over the 15 min observation period. D) Total sum behaviour over the 15 min observation 
period. Data are mean + SEM of 7 mice per group *P<0.05, **P<0.01,***P<0.001, Two-way 
ANOVA followed by Dunnett’s test versus 10 µg in panels A,B and C. One-Way ANOVA 
followed by Dunnett’s test versus 10 µg dose in panel D.  
 
Figure 3. CatS and SLIGRL-NH2 induce itch-like behaviour in the cheek injection model. 
A) Total time spent scratching or wiping on the cheek over the 15 min observation period 
immediately after injection of activated hr-CatS. B) Total time spent scratching or wiping on 
the cheek immediately after injection of SLIGRL-NH2. C) Total time spent scratching or wiping 
on the cheek immediately after injection of chloroquine. D) Total time spent scratching or 
wiping on the cheek immediately after injection of capsaicin.  Data are mean + SEM of 6 mice 
per group. ,* P<0.05,***P<0.001, Student’s t test.  
 
Figure 4. CatS inhibitors and PAR2 antagonist prevent activated Cat-S induced itch-like 
behaviour. A) Total sum behaviour over the 15 min observation period after intradermal 
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injection of activated hr-CatS (20 µg/mouse) and 1 hr pre-treatment with LHVS (30 mg/kg s.c.). 
B) Total sum behaviour over the 15 min observation period after intradermal injection of 
activated hr-CatS (20 µg/mouse) and 1 hr pre-treatment with MDV-590 (200 µmol/kg p.o.). C) 
Total sum behaviour over the 15 min observation period after intradermal injection of activated 
hr-CatS (20 µg/mouse) and 1 hr pre-treatment FSLLRY (50 µg/ mouse, intradermal). D) Total 
sum behaviour over the 15 min observation period after intradermal injection of SLIRGL (50 
µg/mouse) and 1 hr pre-treatment FSLLRY (50 µg/ mouse, intradermal); 
*P<0.05, **P<0.01 ***P<0.001, One Way ANOVA followed by Dunnett’s test versus vehicle 
group.  Data are mean + SEM of 8 animals per group. 
 
Figure 5. Cat-S and SLIGRL-NH2 induced itch-like behaviour in TRPV1-/- and TRPA1-/- 
mice. A) Total sum behaviour over the 15 min observation period after intradermal injection 
of activated hr-CatS (20 µg/mouse) or SLIRGL-NH2 (50 µg/mouse).  
*P<0.05, **P<0.01 ***P<0.001, One Way ANOVA followed by Dunnett’s test versus vehicle 
group.  Data are mean + SEM of 8 animals per group. 
 
Figure 6. Calcium responses in sensory neurons following application of CatS are 
reduced by the PAR2 antagonist and in cultures from TRPV1-/- or TRPA1-/- mice. A) 
Representative traces of the calcium response of a cell that responded to application of hr-
CatS (400 nM). No changes were observed between 200 and 1000 seconds and this is 
reflected in the break of the axis. B) Percentage of sensory neurons in culture that responded 
to buffer or hr-CatS applied for up to 20 minutes, from 461 cells, n = 4, 5 from 1 coverslip per 
mouse. C)  Percentage of sensory neurons in culture that responded to application of hr-CatS 
in the presence of MDV-590 (0.5 µM) or FSLLRY (5 µM), from 663 cells, n = 3, 4 from 1 
coverslip per mouse. D) Percentage of sensory neurons cultured from TRPV1-/- or TRPA1-/- 
mice that responded to application of CatS, from 373 cells, n = 3 – 5 from 1 coverslip per 
mouse. *P≤0.05, One Way ANOVA followed by Dunnett's test versus vehicle incubation. Data 
are mean + SEM.  
